What We're Reading: Page 296
Industry reads hand-picked by our editors
Jun 23, 2017
-
The New York Times
Insurers battle families over costly drug for fatal disease
-
EP Vantage
German Merck doubles down on dual-acting cancer agents
-
Bloomberg
Biotech stock rally may have legs
Jun 22, 2017
-
The New York Times
GSK wins $235 million from Teva in Coreg patent trial
-
EP Vantage
Only Bristol bucks big pharma’s drive for external reliance
-
Financial Times
Pharma recovers composure as price concerns ease
Jun 21, 2017
-
Chemical and Engineering News
U.S. Supreme Court gives pharma a product liability win
-
Reuters
Drugmaker Mylan gets boost from unlikely source: coal
-
Bloomberg Gadfly
So much for Trump going after pharma
Previous
